Advanced Prostate Cancer – Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) *NEW

This course series Advanced Prostate Cancer gives clinicians a complete view on clinical aspects, diagnosis, and treatments of prostate cancer. This course series contains five courses, each of them addresses an important topic in diagnosis, treatment, and management of prostate cancer. Each course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for 1 to 3  European CME credits(ECMEC). The five courses are:

Course 1: Basis of ADT (published in March 2020)
Course 2: Hormone-sensitive nmPCa
Course 3: Metastatic hormone-sensitive PCa (published in June 2020)
Course 4: Non-metastatic CRPC
Course 5: Metastatic CRPC (published in Jan 2021)

This course Non-Metastatic Castration-Resistant Prostate Cancer is the fourth part of the course series.

The development of this course has been supported by Jansen with a concession of an unrestricted educational grant.

Learning Objectives

This series of five e-courses aims to provide HCPs with a complete view of the management of Advanced Prostate Cancer. Users of this training are expected to progress their knowledge in the clinical aspects and management of prostate cancer. Specific learning objectives are as follows:

  • Definition of Hormone sensitive nmPCa / nmPCa / MPCa / CRPC and classification
  • Information about diagnostic tools, how to combine them and the value of their results
  • Information on prognosis factors, predictive factors and patient stratification
  • Information about treatment options, how to combine them, their differences and side-effects, when to progress to the next treatment stage, and how to evaluate these
  • Information on sound clinical decision making for patients with nmPCa, MPCa, Metastatic CRPC, and nmCRPC
  • Evaluation of learners’ knowledge about treatment of nmPCa, MPCa, Metastatic CRPC, and nmCRPC and their ability to apply this knowledge in devising care pathways for patients

Chapters

Chapter 1: Definition and occurrence
Chapter 2: Clarifying metastasis and progression
Chapter 3: Predicting outcomes: the role of PSA-DT
Chapter 4: Treatment

At a glance

  • Publication date: November 2020
  • Last update: May 2021
  • Available languages: English
  • Topic: Prostate cancer
  • Duration: 60-90 minutes approximately
  • CME: 1 European CME credits (ECMEC)

Contributing Authors

Main author:
Prof. Dr. N. Mottet (Chair of the EAU PCa Guidelines Panel)